Purchase Order HHSN261201700703P

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian federal agency, to the National Cancer Center, a Japanese research and development agency. The contract is for $24,000.00 and requires the awardee to provide laboratory testing services, including whole-genome scans and phenotype data preparation, on 1,000 never-smoking female lung adenocarcinoma cases in Japan. The contract has an ultimate completion date of December 9, 2025. This contract...

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>

<p>This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency, to Biosimulation Consulting Inc. for toxicological and toxicokinetic studies of xenobiotics. The contract has a ceiling value of $75,000.00 and a completion date of June 12, 2017. The contract was not set aside for any specific business type. The National Cancer Institute is responsible for the funding of this contract.</p>

<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>

<p>This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services (HHS), to Assay Depot Inc. doing business as Scientist. The contract is for a subscription, license, and maintenance agreement for the CCR/NCI Research Exchange, with a ceiling value of $75,000.00 and a period of performance through March 24, 2016. The contract does not have a set-aside designation.</p>

<p>The National Cancer Institute issued a delivery order to Social &amp; Scientific Systems, Inc. on September 19, 2017, with a ceiling value of $155,909.58 for dosimetry of therapeutic radiation on patient support services for radiation and cancer risk studies.</p> <p>Place of performance is Silver Spring, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 18, 2018. No set-aside was used.</p>

<p>This is a $25,000.00 Firm Fixed Price Purchase Order service agreement awarded by the National Cancer Institute, a civilian federal agency, to Medilumine Inc., a for-profit organization. The contract has an ultimate completion date of June 30, 2025 and was awarded on July 1, 2024. There is no set-aside designation associated with this contract.</p>

<p>This is a $1,784.00 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency, to Battelle Memorial Institute for initial administrative charges related to a pre-clinical toxicology study of a drug being developed for cancer patients. The contract is an order placed under the Toxicology of Drugs Developed for Cancer Patients indefinite-delivery indefinite-quantity (IDIQ) contract vehicle. No set-aside was used for this award.</p>

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute (a civilian agency) to Josiah Ballantine, a for-profit organization, to provide patient on-call services for the Pediatric Oncology Branch from May 1, 2025 to July 15, 2025. The contract has a ceiling value of $11,720.00 and does not have a set-aside designation. The place of performance is Bethesda, MD.</p>